Clinical Trials Directory

Trials / Completed

CompletedNCT05128422

Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke

Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke Patients Within 6-24 Hours of Symptom Onset

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and efficiency of normobaric hyperoxia combined with endovascular treatment for acute ischemic stroke patients with stroke onset 6-24 hours.

Conditions

Interventions

TypeNameDescription
OTHERNormobaric oxygen therapyit is simple to administer via oxygen storage facemask at flow rates of 10 L/min for 4 hours.This therapy should begin in the emergency room as early as possible when patients meet the inclusion criteria and are randomized to the experimental group

Timeline

Start date
2021-10-27
Primary completion
2023-10-15
Completion
2023-10-15
First posted
2021-11-22
Last updated
2024-07-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05128422. Inclusion in this directory is not an endorsement.